Private Health Insurance is a FavourablePrognostic Risk
Factor in the Outcomes of Mortality Post
Radical C ystectomy
Volume 3 - Issue 1
Simon Robinson*, Ailsa Butler, Mufeed Ali and Hanif Motiwala
-
Author Information
Open or Close
- FHFT Department Urology, Oxon dept epidemiology Oxford, Frimley health foundation trust, UK
*Corresponding author:
Simon Robinson, Frimley health foundation trust, FHFT Department Urology, Oxon dept epidemiology
Oxford, FHFT Dept Pathology, UK
Received: July 27, 2020; Published: August 07, 2020
DOI: 10.32474/JUNS.2020.03.000151
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Objectives: There are well recognised differences in health outcomes generally in society due to a range of socio-economic
factors. We have compared survival outcomes in patients undergoing radical cystectomy for aggressive bladder cancer in the
national health service (NHS) and compared this with those with private health insurance (PHI).
Methods: This is retrospective study of 225 NHS and 32 PHI patients operated over 14 years by one surgeon. ASA scores were
compared to approximate comorbidity status.
Results: There were significantly worse outcomes for all cause and disease specific mortality in the NHS group. There was no
difference in ASA scores.
Conclusions: NHS patients fare worse than those with PHI. The reasons for this difference remain unclear. PHI patients have a
more extensive lymphadenectomy and have fewer overall complications.
Keywords: NHS private insurance outcomes radical cystectomy bladder cancer
Abstract|
Introduction|
Methods|
Results|
Discussion|
Progression|
Conclusions|
Limitations|
References|